Recordati Industria Chimica e Farmaceutica S.P.A. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 770.835 million compared to EUR 760.192 million a year ago. Operating income was EUR 250.368 million compared to EUR 261.510 million a year ago. Net income was EUR 207.084 million compared to EUR 196.918 million a year ago.